Drug
0.375% ropivacaine
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_4
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Terminated(1)
Other(1)
Detailed Status
unknown1
Not yet recruiting1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
unknown133%
not_yet_recruiting133%
withdrawn133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
EIT Evaluation of Pulmonary Ventilation With Different Ropivacaine Concentrations in Intercostal Nerve Blockade
NCT07079436
unknownnot_applicable
The Effect of Intercostal Nerve Block With Dexamethasone and Ropivacaine on Rebound Pain After Thoracoscopic Surgery
NCT05825378
withdrawnphase_4
Can Post-operative TAP Block Improve Quality of Recovery After C-sections in Patients on Methadone Maintenance?
NCT01644864
Clinical Trials (3)
Showing 3 of 3 trials
NCT07079436Not Applicable
EIT Evaluation of Pulmonary Ventilation With Different Ropivacaine Concentrations in Intercostal Nerve Blockade
NCT05825378Not Applicable
The Effect of Intercostal Nerve Block With Dexamethasone and Ropivacaine on Rebound Pain After Thoracoscopic Surgery
NCT01644864Phase 4
Can Post-operative TAP Block Improve Quality of Recovery After C-sections in Patients on Methadone Maintenance?
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3